Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
butalbital + acetaminophen + caffeine
- Development stage
- Approved
- Lead developer
- KVK Tech
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
butalbital + acetaminophen + caffeine is a fixed-dose combination product manufactured by KVK-Tech, indicated for the treatment of tension (muscle contraction) headaches. The combination consists of butalbital, a barbiturate that provides sedative and muscle-relaxant effects; acetaminophen, a non-opioid analgesic and antipyretic; and caffeine, a central nervous system stimulant that enhances the analgesic efficacy of the other components. This product is a generic version of the brand-name drug Fioricet. Due to the presence of butalbital, the medication carries a risk of habit-forming potential and abuse.
- Other names
- butalbital, acetaminophen, and caffeine tablets
02
Targets
ADOR (Adenosine receptors)GABRR (GABA-A receptor subunit rho)ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GABA-B (Gamma-aminobutyric acid receptor type B)
Beyond the preview
Go deeper on butalbital + acetaminophen + caffeine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on butalbital + acetaminophen + caffeine.